Recruiting
Phase 3

Puxitatug Samrotecan vs. Chemotherapy

Sponsor:

AstraZeneca

Code:

NCT07044336

Conditions

Endometrial Cancer

Malignant Solid Tumour

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Puxitatug Samrotecan

Doxorubicin

Paclitaxel

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-21. This information was provided to ClinicalTrials.gov by AstraZeneca on 2026-06-10.